Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Share Options

1 Apr 2010 12:26

RNS Number : 6351J
Symphony Environmental Tech. PLC
01 April 2010
 



 

 

1st April 2010

 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

 

Share Options

 

 

Symphony Environmental Technologies Plc ("Symphony", the "Company" or the "Group") announces that the Board, on the recommendation of the Remuneration Committee, granted on 31st March 2010 share options to the Executive Directors of the Company in recognition of the results they have achieved in 2009.

 

A total of 1,050,000 options over the Company's ordinary 1p shares have been granted and allocated as to Michael Laurier 350,000; Ian Bristow 280,000; Michael Stephen 210,000; and Michael Stephens 210,000.

 

The options are exercisable for ten years at 9.125p per ordinary share being the mid market price on 31 March 2010.

 

Contacts:

 

Symphony Environmental Technologies plc

Michael Laurier, CEO

Ian Bristow, FD

  Tel: 020 8207 5900

 

Allenby Capital Limited

Nick Naylor/James Reeve

 

Tel: 020 3328 5656

Threadneedle Communications

Graham Herring/Josh Royston

 

Tel: 020 7653 9850

 

Symbol London. SYM.L

 

American Depositary Receipts ("ADR")

Symphony ADRs trade in the US on the OTC (Over The Counter) market under the symbol SETPY. The ADR to 1p ordinary share ratio is 1:100 and the CUSIP is 87156K104. BNY Mellon acts as sponsored depositary for Symphony's ADR facility.

 

 

Further information on the Symphony Environmental Technologies Group of companies:

 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC considers itself a world leader in Controlled-life plastic technology and products - a system that works by a process called oxo-biodegradation. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products.

 

Symphony has a diverse and growing customer-base and has established itself successfully as an international business. Products made with d2w plastic technology can now be found in more than 90 countries around the world and in many different product applications. Symphony is a member of the Oxo-biodegradable Plastics Association (www.biodeg.org), the Society for the Chemical Industry (UK), and the American Standards Organisation (ASTM). Symphony is also a member of The US Save the Plastic Bag Coalition (http://www.savetheplasticbag.com/) and the British Brands Group. Symphony actively participates in the work of the British Standards Institute (BSI) and the European Standards Organisation (CEN).

 

Symphony also owns d2p which is an anti-microbial technology that is used in most type of plastic product applications to help protect those products against bacteria and fungi growth. Symphony is also developing innovative and cost-effective waste-to-value technology to convert plastics, tyres and other waste-streams into valuable products.

 

Further information on the Symphony Group can be found at www.d2w.net.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSIFFFFSSEEL
Date   Source Headline
25th Mar 20243:02 pmRNSReplacement - Subscription and Notice of GM
22nd Mar 20247:01 amRNSPrimaryBid Offer
22nd Mar 20247:00 amRNSSubscription, PrimaryBid Offer and Notice of GM
14th Mar 20247:00 amRNSExtension to Convertible Loan Agreements
13th Mar 20247:00 amRNSUS Environmental Protection Agency positive report
9th Feb 20247:59 amRNSEU Judgment – Company Response
31st Jan 20249:48 amRNSEU Court Judgement
18th Jan 20247:00 amRNSTrading Update and EU Case
8th Jan 20247:00 amRNSGrant of options and PDMR dealing
2nd Jan 20247:00 amRNSDirector appointment & grant of options
28th Dec 20237:00 amRNSOptions amendments
18th Oct 20232:10 pmRNS£1.0m convertible loan agreement
29th Sep 20237:00 amRNSInterim Results
26th Sep 20237:00 amRNSYemen Enforces Oxo-Biodegradable Plastic Law
11th Aug 20237:00 amRNSDirectorate Change
1st Aug 20237:00 amRNSPre-close Trading Update
4th Jul 20237:00 amRNSDirectorate Change
29th Jun 20231:46 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
7th Jun 20238:34 amRNSPosting of Annual Report & Accounts & AGM Notice
30th May 20237:00 amRNSPreliminary Results
21st Mar 20237:00 amRNSEU court hearing
13th Mar 20233:40 pmRNSConvertible loan agreement & revenue update
9th Mar 20237:00 amRNSd2w BioBottles supply agreement with TricorBraun
23rd Dec 20227:00 amRNSTrading update
31st Oct 20227:00 amRNSAttendance at world’s leading plastics trade fair
28th Oct 20222:51 pmRNSDirector/PDMR Shareholdings – Option amendments
29th Sep 20229:00 amRNSInvestor Presentation
29th Sep 20227:01 amRNSSymphony India operations update
29th Sep 20227:00 amRNSInterim results for the 6 m/e 30 June 2022
9th Aug 20227:00 amRNSMexican Technical Standard Validating d2w
8th Aug 20227:00 amRNSAgreement for Middle East manufacturing
1st Aug 20227:01 amRNSEquity subscription and grant of warrants
1st Aug 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSd2p Anti-Insect Sales
29th Jun 20222:00 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
28th Jun 20227:00 amRNSd2p Supply Agreement with Grupo Bimbo
27th Jun 20227:00 amRNSPeru legal action outcome
7th Jun 20227:00 amRNSPosting of Annual Report and Notice of AGM
18th May 20227:00 amRNSAppointment of Executive Director
4th May 20227:00 amRNSGrant of Options
20th Apr 20227:00 amRNSSymphony India Sustainability Award
30th Mar 20227:00 amRNSPreliminary results
24th Feb 20223:49 pmRNSExtension of options
23rd Feb 20227:00 amRNSNew US Supply Contract
17th Dec 20212:09 pmRNSTrading and business update
29th Nov 20217:00 amRNSPositive DEFRA consultation
19th Nov 20212:54 pmRNSDirector/PDMR Shareholding - options amendment
19th Nov 20212:11 pmRNSDirector/PDMR Shareholding - option amendments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.